Additionally, urinary sialic acid was found to have greater excretion in pediatric patients with CD versus UC, reflecting differences in IBD pathophysiology (Figure 2, Table 2), while also being correlated with FCP and serum CRP following induction therapy (Supplementary Figure S9). This evidence concerns the gene CRP and irritable bowel syndrome.